Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

13 Dec 2018 10:22

RNS Number : 3946K
GoldmanSachs International
13 December 2018
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SHIRE PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

SHIRE PLC

(d) Date dealing undertaken:

12 December 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - disclosed previously for TAKEDA PHARMACEUTICAL COMPANY LIMITED

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Purchases

3,295,521571,088

45.6500 GBP57.6956 USD

45.2950 GBP57.1572 USD

Ordinary

Sales

1,327,995736,298

45.5750 GBP57.2005 USD

45.3175 GBP56.9011 USD

ADR / (1.00 : 3.00)

Purchases

419 (1,257)

173.0500 USD

172.8025 USD

ADR / (1.00 : 3.00)

Sales

419 (1,257)

173.0500 USD

172.8025 USD

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary

CFD

Reducing a short position

21

45.4000 GBP

Ordinary

CFD

Increasing a short position

5,345

45.4239 GBP

Ordinary

CFD

Reducing a long position

1,012

45.4329 GBP

Ordinary

CFD

Reducing a long position

2,807

45.4329 GBP

Ordinary

CFD

Reducing a short position

19,776

45.4369 GBP

Ordinary

CFD

Reducing a short position

38

45.4369 GBP

Ordinary

CFD

Reducing a short position

55

45.4369 GBP

Ordinary

CFD

Reducing a short position

346

45.4369 GBP

Ordinary

CFD

Reducing a short position

46

45.4369 GBP

Ordinary

CFD

Reducing a short position

41

45.4369 GBP

Ordinary

CFD

Reducing a short position

10

45.4369 GBP

Ordinary

CFD

Reducing a short position

60,719

45.4369 GBP

Ordinary

CFD

Reducing a short position

24

45.4369 GBP

Ordinary

CFD

Reducing a short position

15

45.4369 GBP

Ordinary

CFD

Reducing a short position

23

45.4369 GBP

Ordinary

CFD

Reducing a short position

2,342

45.4369 GBP

Ordinary

CFD

Reducing a short position

58

45.4369 GBP

Ordinary

CFD

Reducing a short position

27

45.4369 GBP

Ordinary

CFD

Reducing a short position

6

45.4369 GBP

Ordinary

CFD

Reducing a short position

20

45.4369 GBP

Ordinary

CFD

Reducing a long position

33,907

45.4399 GBP

Ordinary

CFD

Increasing a short position

4,592

45.4481 GBP

Ordinary

CFD

Increasing a long position

4,390

45.4640 GBP

Ordinary

CFD

Reducing a short position

1,805

45.4751 GBP

Ordinary

CFD

Reducing a short position

2,882

45.5424 GBP

Ordinary

CFD

Opening a short position

2,979

57.1572 USD

Ordinary

CFD

Reducing a short position

277

57.1903 USD

Ordinary

CFD

Reducing a short position

2,400

57.1903 USD

Ordinary

CFD

Reducing a short position

1,300

57.1903 USD

Ordinary

CFD

Reducing a short position

2,600

57.1903 USD

Ordinary

CFD

Reducing a short position

900

57.1903 USD

Ordinary

CFD

Reducing a short position

100

57.1903 USD

Ordinary

CFD

Reducing a short position

3,000

57.1903 USD

Ordinary

CFD

Reducing a short position

1,900

57.1903 USD

Ordinary

CFD

Reducing a short position

500

57.1903 USD

Ordinary

CFD

Reducing a short position

700

57.1903 USD

Ordinary

CFD

Reducing a short position

1,900

57.1903 USD

Ordinary

CFD

Reducing a short position

628

57.1903 USD

Ordinary

CFD

Reducing a short position

17,248

57.1903 USD

Ordinary

CFD

Reducing a short position

2,500

57.1903 USD

Ordinary

CFD

Reducing a short position

700

57.1903 USD

Ordinary

CFD

Reducing a short position

1,500

57.1903 USD

Ordinary

CFD

Reducing a short position

2,000

57.1903 USD

Ordinary

CFD

Reducing a short position

9

57.1903 USD

Ordinary

CFD

Opening a short position

10,000

57.2526 USD

Ordinary

CFD

Opening a short position

100,000

57.2821 USD

Ordinary

CFD

Opening a short position

50,000

57.3236 USD

Ordinary

CFD

Opening a short position

5,971

57.4218 USD

Ordinary

CFD

Opening a short position

2,301

57.4218 USD

Ordinary

CFD

Increasing a short position

100,000

57.4314 USD

Ordinary

CFD

Increasing a short position

100,000

57.4314 USD

Ordinary

CFD

Opening a short position

145,000

57.5088 USD

Ordinary

CFD

Increasing a short position

60,000

57.5366 USD

Ordinary

CFD

Increasing a short position

60,000

57.5366 USD

Ordinary

CFD

Opening a short position

100,000

57.5951 USD

Ordinary

CFD

Increasing a short position

34,837

57.6956 USD

Ordinary

SWAP

Reducing a short position

10,980

45.4397 GBP

Ordinary

SWAP^

Reducing a long position

935,103

45.6000 GBP

Ordinary

SWAP

Reducing a short position

46,662

56.9011 USD

Ordinary

SWAP

Opening a long position

259,982

56.9639 USD

Ordinary

SWAP

Reducing a short position

121,970

57.2005 USD

Ordinary

SWAP

Reducing a short position

267,522

57.2005 USD

^Please note this product is part of a basket of securities for which SHIRE PLC is a component

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

5 (1,500)

172.5000 USD

AMERICAN

21/12/2018

2.3560 USD

ADR / (1.00 : 3.00)

Put Option / (1.00 : 300.00)

Purchasing

5 (1,500)

160.0000 USD

AMERICAN

21/12/2018

0.3820 USD

ADR / (1.00 : 3.00)

Put Option / (1.00 : 300.00)

Selling

5 (1,500)

165.0000 USD

AMERICAN

21/12/2018

0.4140 USD

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

13 December 2018

Contact name:

Kashif Rafiq and Papa Lette

Telephone number:

+44(20) 7051 0547 / +44(20) 7774 7442

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERBGBDDIBBBGIX
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.